727 related articles for article (PubMed ID: 32056910)
41. Fecal Microbiota Transplant for Irritable Bowel Syndrome: Panacea or Placebo?
Shaukat A; Brenner DM
Am J Gastroenterol; 2019 Jul; 114(7):1032-1033. PubMed ID: 31082878
[TBL] [Abstract][Full Text] [Related]
42. Comparison of comorbid depression between irritable bowel syndrome and inflammatory bowel disease: A meta-analysis of comparative studies.
Geng Q; Zhang QE; Wang F; Zheng W; Ng CH; Ungvari GS; Wang G; Xiang YT
J Affect Disord; 2018 Sep; 237():37-46. PubMed ID: 29758449
[TBL] [Abstract][Full Text] [Related]
43. Gut Non-Bacterial Microbiota: Emerging Link to Irritable Bowel Syndrome.
Liu A; Gao W; Zhu Y; Hou X; Chu H
Toxins (Basel); 2022 Aug; 14(9):. PubMed ID: 36136534
[TBL] [Abstract][Full Text] [Related]
44. Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome.
Harris LA; Baffy N
Postgrad Med; 2017 Nov; 129(8):872-888. PubMed ID: 28936910
[TBL] [Abstract][Full Text] [Related]
45. Higher prevalence of irritable bowel syndrome and greater gastrointestinal symptoms in obsessive-compulsive disorder.
Turna J; Grosman Kaplan K; Patterson B; Bercik P; Anglin R; Soreni N; Van Ameringen M
J Psychiatr Res; 2019 Nov; 118():1-6. PubMed ID: 31437616
[TBL] [Abstract][Full Text] [Related]
46. Gut Microbiota-Derived Metabolites in Irritable Bowel Syndrome.
Xiao L; Liu Q; Luo M; Xiong L
Front Cell Infect Microbiol; 2021; 11():729346. PubMed ID: 34631603
[TBL] [Abstract][Full Text] [Related]
47. Fecal microbiota transplantation for managing irritable bowel syndrome.
El-Salhy M; Mazzawi T
Expert Rev Gastroenterol Hepatol; 2018 May; 12(5):439-445. PubMed ID: 29493330
[TBL] [Abstract][Full Text] [Related]
48. Randomised clinical trial: faecal microbiota transplantation versus autologous placebo administered via colonoscopy in irritable bowel syndrome.
Lahtinen P; Jalanka J; Hartikainen A; Mattila E; Hillilä M; Punkkinen J; Koskenpato J; Anttila VJ; Tillonen J; Satokari R; Arkkila P
Aliment Pharmacol Ther; 2020 Jun; 51(12):1321-1331. PubMed ID: 32343000
[TBL] [Abstract][Full Text] [Related]
49. Bifico relieves irritable bowel syndrome by regulating gut microbiota dysbiosis and inflammatory cytokines.
Zhou Y; Zhang F; Mao L; Feng T; Wang K; Xu M; Lv B; Wang X
Eur J Nutr; 2023 Feb; 62(1):139-155. PubMed ID: 35918555
[TBL] [Abstract][Full Text] [Related]
50. Altered molecular signature of intestinal microbiota in irritable bowel syndrome patients compared with healthy controls: A systematic review and meta-analysis.
Liu HN; Wu H; Chen YZ; Chen YJ; Shen XZ; Liu TT
Dig Liver Dis; 2017 Apr; 49(4):331-337. PubMed ID: 28179092
[TBL] [Abstract][Full Text] [Related]
51. Food Additives, Gut Microbiota, and Irritable Bowel Syndrome: A Hidden Track.
Rinninella E; Cintoni M; Raoul P; Gasbarrini A; Mele MC
Int J Environ Res Public Health; 2020 Nov; 17(23):. PubMed ID: 33260947
[TBL] [Abstract][Full Text] [Related]
52. The impact of depression-mediated gut microbiota composition on Irritable Bowel Syndrome: A Mendelian study.
Huang Y; Zheng E; Hu M; Yang X; Lan Q; Yu Y; Xu B
J Affect Disord; 2024 Sep; 360():15-25. PubMed ID: 38801922
[TBL] [Abstract][Full Text] [Related]
53. A starch- and sucrose-reduced dietary intervention in irritable bowel syndrome patients produced a shift in gut microbiota composition along with changes in phylum, genus, and amplicon sequence variant abundances, without affecting the micro-RNA levels.
Nilholm C; Manoharan L; Roth B; D'Amato M; Ohlsson B
United European Gastroenterol J; 2022 May; 10(4):363-375. PubMed ID: 35484927
[TBL] [Abstract][Full Text] [Related]
54. Review article: evidence for the role of gut microbiota in irritable bowel syndrome and its potential influence on therapeutic targets.
Dupont HL
Aliment Pharmacol Ther; 2014 May; 39(10):1033-42. PubMed ID: 24665829
[TBL] [Abstract][Full Text] [Related]
55. Relief of irritable bowel syndrome by fecal microbiota transplantation is associated with changes in diversity and composition of the gut microbiota.
Huang HL; Chen HT; Luo QL; Xu HM; He J; Li YQ; Zhou YL; Yao F; Nie YQ; Zhou YJ
J Dig Dis; 2019 Aug; 20(8):401-408. PubMed ID: 31070838
[TBL] [Abstract][Full Text] [Related]
56. The Role of Gut-Microbiota in the Pathophysiology and Therapy of Irritable Bowel Syndrome: A Systematic Review.
Shrestha B; Patel D; Shah H; Hanna KS; Kaur H; Alazzeh MS; Thandavaram A; Channar A; Purohit A; Venugopal S
Cureus; 2022 Aug; 14(8):e28064. PubMed ID: 36127988
[TBL] [Abstract][Full Text] [Related]
57. The level and prevalence of depression and anxiety among patients with different subtypes of irritable bowel syndrome: a network meta-analysis.
Hu Z; Li M; Yao L; Wang Y; Wang E; Yuan J; Wang F; Yang K; Bian Z; Zhong LLD
BMC Gastroenterol; 2021 Jan; 21(1):23. PubMed ID: 33413140
[TBL] [Abstract][Full Text] [Related]
58. The effect of fecal microbiota transplantation on psychiatric symptoms among patients with irritable bowel syndrome, functional diarrhea and functional constipation: An open-label observational study.
Kurokawa S; Kishimoto T; Mizuno S; Masaoka T; Naganuma M; Liang KC; Kitazawa M; Nakashima M; Shindo C; Suda W; Hattori M; Kanai T; Mimura M
J Affect Disord; 2018 Aug; 235():506-512. PubMed ID: 29684865
[TBL] [Abstract][Full Text] [Related]
59. Diet and gut microbiome interactions of relevance for symptoms in irritable bowel syndrome.
Tap J; Störsrud S; Le Nevé B; Cotillard A; Pons N; Doré J; Öhman L; Törnblom H; Derrien M; Simrén M
Microbiome; 2021 Mar; 9(1):74. PubMed ID: 33771219
[TBL] [Abstract][Full Text] [Related]
60. Microbial and metabolomic profiles in correlation with depression and anxiety co-morbidities in diarrhoea-predominant IBS patients.
Liu T; Gu X; Li LX; Li M; Li B; Cui X; Zuo XL
BMC Microbiol; 2020 Jun; 20(1):168. PubMed ID: 32552668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
